Fustibal

Curated by Signal

Provider of targeted drug therapy

Overview

Fustibal is developing data-based computational platforms for targeted therapeutics and companion diagnostics. It develops targeted nanomedicines via modular drug design by repurposing and improving existing pharmaceuticals for efficacy, safety, and unmet medical needs. The platforms are kinetics-based, genetics-based, proteomic-driven and, therapeutics are cancer-focused but have broad medical applications.

Key facts

Founded: 2014
Headquarters: San Francisco, United States
Stage: Sign up to view
Industry: Health Technology

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Alchemiss
Provider of cannabis-derived nutritional and wellness products
Health TechnologyTampa, United States
Enzyme
Cloud-based software solution for quality & FDA compliance
Health TechnologySan Francisco, United States
IngMar Medical
Lung simulation products to train clinicians
Health TechnologyPittsburgh, United States

About Fustibal

What does Fustibal do?

Fustibal is developing data-based computational platforms for targeted therapeutics and companion diagnostics.

Where is Fustibal headquartered?

Fustibal is headquartered in San Francisco, United States.

When was Fustibal founded?

Fustibal was founded in 2014.

Which sector is Fustibal in?

Fustibal operates in Health Technology.

Who are Fustibal's competitors?

Companies similar to Fustibal include Alchemiss, Enzyme, and IngMar Medical.